(Q74823204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

P K Linden

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

5A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

24S-33S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Coagulase-negative staphylococci: pathogens associated with medical progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Evaluation of coagulase-negative staphylococci in blood cultures. A prospective clinical and microbiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

The positive predictive value of isolating coagulase-negative staphylococci from blood cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Update on clinical significance of coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Consequences of intravascular catheter sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Methicillin-resistant Staphylococcus aureus bacteraemia in Hong Kong.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Sources and outcome for methicillin-resistant Staphylococcus aureus bacteraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

An Outbreak of Infections Caused by Strains of Staphylococcus aureus Resistant to Methicillin and Aminoglycosides. I. Clinical Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Selective decontamination of the digestive tract and methicillin-resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Emergence of vancomycin resistance in coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Peritonitis due to vancomycin-resistant Staphylococcus epidermidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

The specter of glycopeptide resistance: current trends and future considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Vancomycin therapy for methicillin-resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Morbidity and mortality of an endemic pathogen: methicillin-resistant Staphylococcus aureus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Staphylococcus aureus and vancomycin: the sequel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Enterococcal bacteremia: to treat or not to treat, a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

High-level gentamicin resistance in Enterococcus faecalis bacteremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Stool Carriage, Clinical Isolation, and Mortality During an Outbreak of Vancomycin-Resistant Enterococci in Hospitalized Medical and/or Surgical Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

An old antibiotic for a new multiple-resistant Enterococcus faecium?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900152-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00152-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684655%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference